{"SPADE_N_13575": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13575", "Peptide Name": "Humimycin B (human microbiome mycin B, Tyr-rich; natural AMPs; lipopeptide; nonribosomal peptide; XXL; XXD2; microbiome, bacteria, prokaryotes; UCLL1c)", "Source": "human microbiota", "Family": "Not found", "Gene": "Not found", "Sequence": "YSYYTIV", "Sequence Length": 7, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Antifungal", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 908.0, "PI": 5.52, "Hydrophobicity": 0.47, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Chu J, Vila-Farres X, Inoyama D, Ternei M, Cohen LJ, Gordon EA, Reddy BV, Charlop-Powers Z, Zebroski HA, Gallardo-Macias R, Jaskowski M, Satish S, Park S, Perlin DS, Freundlich JS, Brady SF. 2016", "Reference": "Nat Chem Biol . 2016 Dec;12(12):1004-1006. doi: 10.1038/nchembio.2207.PubMed", "Title": "Discovery of MRSA active antibiotics using primary sequence from the human microbiome"}], "Frequent Amino Acids": "YIS", "Absent Amino Acids": "ACDEFGHKLMNOPQRUW", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 6, "Positive Residues": 0, "Negative Residues": 0, "Net Charge": 0, "Comments": "APD analysis reveals that the sequence of this peptide shows 71.4% similarity toHumimycin A. Note: Y3, T5 are D-amino acids. The N-terminus of the peptide is acylated with a C14 carbon fatty acid with hydroxylation at gamma carbon. Active against R. mucilaginosa, R. dentocariosa, Eubacterium spp., 3_1_31, S. aureus (MRSA), S. mitis, S. mutans, S. delphini, S. intermedius, S. pseudintermedius, S. pneumoniae, S. sanguinis (MIC 4-32 ug/ml).  The original synthetic peptide has been replaced. 9/2020; 4/2024", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05940", "Similarity": 1.0, "Sequence": "AFTCHCRRSCYSTEYSY"}, {"SPADE_ID": "SPADE_N_05944", "Similarity": 1.0, "Sequence": "TCHCRRSCYSTEYSY"}, {"SPADE_ID": "SPADE_N_05953", "Similarity": 1.0, "Sequence": "RSCYSTEYSY"}]}}}